Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Larisa E. Gurevich"'
Autor:
Nataliya V. Blinova, Irena A. Ilovayskaya, Novella M. Chikhladze, Anna Yu. Lugovskaya, Timur A. Britvin, Larisa E. Gurevich, Lidia N. Nefedova, Valentina E. Shikina, Irina E. Chazova
Publikováno v:
Терапевтический архив, Vol 96, Iss 7, Pp 645-658 (2024)
The understanding of the nature of catecholamine-secreting tumors has changed significantly in recent years, affecting terminology and classification. Phaeochromocytoma/paraganglioma (PCC/PG) is a rare neuroendocrine tumor from chromaffin tissue that
Externí odkaz:
https://doaj.org/article/b29604c3eb9145b09ecece61c2b718ba
Autor:
Iya A. Voronkova, Anastasiya M. Lapshina, Larisa E. Gurevich, Ludmila Ya. Rozhinskaya, Timur A. Britvin, Alexey V. Krivosheev, Ilya V. Kim, Sergey N. Kuznetsov, Natalia G. Mokrysheva
Publikováno v:
Клиническая и экспериментальная тиреоидология, Vol 13, Iss 4, Pp 40-48 (2018)
Most clinicians are well aware of the coexistence of medullary thyroid cancer and hyperparathyroidism in hereditary and sporadic multiple endocrine neoplasia syndromes. Тhe reported incidence of nonmedullary thyroid carcinoma in patients with primar
Externí odkaz:
https://doaj.org/article/69b95104be7441e393574e7406ad9e8c
Autor:
Natalia Mokrysheva, A. M. Lapshina, Larisa E. Gurevich, Sergey N. Kuznetsov, I V Kim, Timur Britvin, Ludmila Rozhinskaya, Alexey V. Krivosheev, Iya Voronkova
Publikováno v:
Клиническая и экспериментальная тиреоидология, Vol 13, Iss 4, Pp 40-48 (2018)
Most clinicians are well aware of the coexistence of medullary thyroid cancer and hyperparathyroidism in hereditary and sporadic multiple endocrine neoplasia syndromes. Тhe reported incidence of nonmedullary thyroid carcinoma in patients with primar
Autor:
Zhivotov Va, Anastasiya Mikhaylovna Lapshina, I A Voronkova, L Y Rozhinskaya, N S Kuznetsov, Larisa E. Gurevich, E. I. Marova, Oleg Borisovich Zharkov, Galina Polyakova, Svetlana Arapova
Publikováno v:
Ожирение и метаболизм, Vol 12, Iss 3, Pp 46-52 (2015)
Ectopic secretion of ACTH from non-pituitary tumors, referred to as ectopic ACTH syndrome (EAS), accounts for about 10–20% of Cushing’s syndrome (CS). Ectopic hormone-secreting pheochromocytomas (Pheo) are rare. The first publication of associati